CJC-1295 is a synthetic peptide designed to act as an analog of growth hormone-releasing hormone (GHRH). It is primarily studied for its effects on the body's growth hormone and IGF-1 signaling pathways.
Research interest includes:
Growth hormone release and regulation
IGF-1 signaling
Body-composition and metabolic pathways
Muscle growth and recovery research
Sleep and recovery mechanisms
Healthy-aging research
For educational purposes only. Not intended to diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare professional regarding appropriate use, dosing, interactions, and potential risks.
